Cover image not available

The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen : a systematic review

Publication Data

Title The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen : a systematic review
Contributors Nigel Fleeman, National Co-ordinating Centre for HTA, NHS R & D HTA Programme
Publisher Prepress Projects Ltd. on behalf of NETSCC, HTA
Publication date 2011
Publication location Perth
Language English

Topics

Cytochrome P-450 CYP2D6
Tamoxifen
Breast :: Cancer :: Genetic aspects
Genetic screening :: Evaluation
Genetic screening :: Cost effectiveness

Catalogue Data

OBNB ID GBB1D0624
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99449061

ISBD

P1053 xix, 102 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen : a systematic review. Published by Prepress Projects Ltd. on behalf of NETSCC, HTA in 2011. Publication and catalogue information, links to buy online and reader comments.